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Abstract
Proteomic and lipidomic profiling was performed over a time course of acute hepatitis C virus (HCV) infection in cultured
Huh-7.5 cells to gain new insights into the intracellular processes influenced by this virus. Our proteomic data suggest that
HCV induces early perturbations in glycolysis, the pentose phosphate pathway, and the citric acid cycle, which favor host
biosynthetic activities supporting viral replication and propagation. This is followed by a compensatory shift in metabolism
aimed at maintaining energy homeostasis and cell viability during elevated viral replication and increasing cellular stress.
Complementary lipidomic analyses identified numerous temporal perturbations in select lipid species (e.g. phospholipids
and sphingomyelins) predicted to play important roles in viral replication and downstream assembly and secretion events.
The elevation of lipotoxic ceramide species suggests a potential link between HCV-associated biochemical alterations and
the direct cytopathic effect observed in this in vitro system. Using innovative computational modeling approaches, we
further identified mitochondrial fatty acid oxidation enzymes, which are comparably regulated during in vitro infection and
in patients with histological evidence of fibrosis, as possible targets through which HCV regulates temporal alterations in
cellular metabolic homeostasis.
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Introduction
Persistent infection with hepatitis C virus (HCV), a single-
stranded positive RNA virus of the Flaviviridae family, is a major
cause of liver disease and a global public health problem.
Chronically infected individuals develop variable degrees of
hepatic inflammation and fibrosis, and are at increased risk for
developing cirrhosis and hepatocellular carcinoma [1]. Current
therapy consists of a combination of drugs that target cellular
functions, including pegylated-interferon to boost the interferon-
mediated antiviral response, and ribavirin, a nucleoside analog
that suppresses HCV replication by impairing guanine nucleo-
tide biosynthesis [2]. Unfortunately, this treatment regimen has
limited efficacy, especially for certain HCV genotypes and patient
populations, and its poor tolerability often leads to discontinuation.
All viruses rely on constituents of the host cell to provide the
energy, macromolecules and structural organization necessary for
their propagation. This dependence on host interactions has led
to significant interest in better understanding those pathways/
processes crucial to the viral life cycle, as these represent potential
targets for new antiviral strategies [2–4]. HCV infection has long
been associated with abnormalities in lipid metabolism, and lipids
have been shown to play important roles in various aspects of the
virus life cycle [2,3,5]. For example, the biosynthesis of cholesterol,
fatty acids, and geranylgeranyl and sphingolipid species is key
to HCV replication, presumably by promoting the formation of
lipid rafts on which replicase complexes assemble [6–10]. The
development of a cell culture system that supports not only HCV
replication but also the production of infectious virus has revealed
additional roles for lipid metabolism in viral particle assembly,
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function in the assembly of infectious particles, and HCV
production is further dependent on apolipoprotein B (apoB)
expression and very low density lipoprotein (VLDL) assembly and
secretion [11–13]. The association of HCV morphogenesis with
VLDL production has led to the identification of new cellular
targets (e.g. apoB, microsomal triglyceride transfer protein, and
long chain acyl –coenzyme A synthetase 3) with the potential to
limit both processes [12–15]. Lipidomic analyses of mature virions
isolated from infected-cell culture supernatants suggest that the
HCV membrane is enriched in cholesterol; modulation of the
virion-associated cholesterol or sphingomyelin composition alters
infectivity by inhibiting virus internalization [16]. Host cell lipid
metabolism is therefore critical for multiple stages of the HCV life
cycle, and represents an important area for the exploration of new
antiviral reagents.
Despite the demonstrated importance of lipid components,
the extent to which HCV modulates global intracellular
metabolism to create an environment for RNA replication and
production of progeny particles is currently unknown. Here
we use liquid chromatography-mass spectrometry (LC-MS)
together with the AMT tag approach to identify alterations in
the host cell proteome and lipidome occurring in response to in
vitro infection of Huh-7.5 cells with a chimeric HCV genotype 2a
virus, J6/JFH-1. Our data reveal a temporal sequence of
modifications to the host proteome that were not predicted from
our previous gene expression analyses [17], suggesting that HCV
dramatically disrupts cellular metabolic homeostasis via post-
transcriptional regulatory mechanisms. We also observe global
changes in lipid abundance, which are predicted to impact
the HCV life cycle and pathogenesis. We further describe a
computational modeling approach, which uses these high-
throughput datasets to infer regulatory and functional relationship
networks that provide information about the systems-level role of
key proteins and lipids important for HCV-associated metabolic
reprogramming.
Materials and Methods
Generation of Cell Culture Virus and Experimental
Infections
Approximately 7610
6 Huh-7.5 cells (human hepatoma cell line)
were electroporated with 2 mgo fin vitro transcribed RNA,
representing the chimeric HCV genome J6/JFH-1 [18]. One
source of virus used for the infection experiments consisted of a
pool of adapted virions obtained from cell culture supernatants
that had been passaged multiple times following electroporation
(HCVcc ‘pool’; refer to [17]). Alternatively, a J6/JFH-1 chimeric
genome containing twelve cell culture adaptive mutations (HCVcc
‘clone’), isolated from the HCVcc ‘pool’, was used to generate
virus stocks directly from electroporated cell supernatants by
collecting samples every 12 h over 2–5 days post-electroporation.
Both sources of virus demonstrated enhanced viral kinetics
(.10-fold viral titer compared to parent; manuscript in prepara-
tion, Rice CM) that was necessary to infect the large number of
cells required for the proteomic analysis. Parallel electroporations
were performed in the absence of HCV RNA to generate a control
supernatant sample (‘mock’). In addition, the HCV stock was used
to generate a UV-inactivated, non-infectious control (UV-HCVcc;
refer to [17]). For infection experiments (n=4), low passage Huh-
7.5 cells were seeded at a density of ,3610
6 cells/p150 plate, to
ensure that cells would not reach confluency by the time of
harvest, and treated for ,8–12 h with 20 ml of supernatant
containing virus (HCVcc), UV-inactivated virus (UV-HCVcc), or
conditioned media (mock, CM). Following initial exposure, the
supernatant was replaced with fresh media and incubated until
harvest at 24, 48, or 72 h post-infection. The multiplicity of
infection (MOI) for the experiments was ,1–2 and resulted in
.50% of cells being infected by 24 hours after HCVcc exposure.
Harvesting Cells After Virus Infection
Following removal of supernatant, cells were washed once with
PBS and then scraped from the plate(s) in ice cold PBS. Identically
treated cells were pooled from replicate plates, if necessary, to
obtain approximately 10
7 total cells per time point per condition.
The cells were subsequently split into several fractions: 10% for
RNA isolation for previously reported genomics analyses [17],
10% for lipidomic analysis, and 80% for peptide generation/
proteomic analysis.
Lipidomic Sample Preparation
Cells were pelleted in a siliconized microfuge tube, followed by
disruption with chloroform:methanol (2:1 ratio), and pre-chilled to
220uC. After several rounds of vortexing on ice, samples were
centrifuged at 2,000 RPM for 10 minutes to separate a water-
soluble fraction (upper layer) and a lipid soluble fraction (lower
layer). Both fractions were dried in a speed vac and stored at
280uC until analysis.
Proteomic Sample Preparation
Cells were washed in 0.5 x PBS, pelleted, and stored at 280uC
until sample preparation. Samples from all time points were
prepared on the same day, initially by lysing the thawed cell pellets
in hypotonic buffer (5 mM K3PO4) at room temperature. Samples
were solubilized and denatured by adding trifluoroethanol (TFE)
to achieve a final concentration of 50%, followed by sonication on
ice and incubation at 60uC for 1 h along with additional
sonication. An equal volume of 500 mM NH4HCO3 (pH 8.0)
was added to adjust to pH 8.0, and 5 mM tributylphosphine
(TBP) was then added for 1 h at 37uC to allow reduction of
disulfide bonds. Following centrifugation, soluble material was
Author Summary
As parasites, viruses rely on the cells they infect to provide
the energy and building blocks required for their survival
and propagation. However, relatively little is known about
the extent to which viruses modulate host cell metabolism
and the consequences of these disruptions. Here we
integrate proteomic and lipidomic profiling with compu-
tational modeling approaches to probe the impact of HCV
infection on the global metabolism of cultured hepatoma
cells, and to understand the potential contribution of such
perturbations to viral pathogenesis. Our findings suggest
that increases in host catabolic and biosynthetic activities
occur early during infection, providing the host macro-
molecules necessary for viral growth. As infection pro-
gresses and cellular stress increases, however, a compen-
satory metabolic shift occurs in an attempt to maintain
energy homeostasis and cell viability. This shift is
accompanied by changes in lipid abundance, which has
predicted consequences for the viral life cycle and
pathogenesis. Computational modeling was then used to
identify novel host proteins functioning as key regulators
of this HCV-associated metabolic reprogramming. In
summary, these studies provide new insights into the
marked disruption of cellular metabolic homeostasis that
occurs during HCV infection and that may contribute to
liver disease progression.
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to ,100 ml using a speed vac. Additional NH4HCO3 (50 mM)
was then added to reduce the amount of TFE in the samples to
,10%. Protein concentration was determined using BCA protein
assay (Thermo Scientific) and the denatured and reduced proteins
were subsequently digested in sequencing-grade trypsin (50:1–
100:1, w/w; Promega #V5111) for ,6 h at 37uC. Peptide
concentration was then determined using BCA protein assay and
samples were stored at 280uC until analysis. Prior to mass
spectrometric analysis, all peptide samples were loaded on a 1 ml
solid-phase extraction (SPE) C18 column (Supelco, Bellefonte, PA)
and washed with 4 ml of 0.1% trifluoroacetic acid (TFA)/5%
acetonitrile (ACN). Peptides were eluted from the SPE column
with 1 ml of 0.1% TFA/80% ACN and lyophilized.
Trypsin-Catalyzed
16O/
18O Labeling of Huh-7.5 Cell
Culture Protein Digests
Prior to trypsin-catalyzed
16O/
18O labeling the samples were
reconstituted in 25 mM ammonium bicarbonate (NH4HCO3) and
the peptide concentration was measured using the BCA protein
assay (Pierce) in order to normalize for protein content. Trypsin-
catalyzed
16O/
18O labeling was carried out as described
previously [19,20]. Peptides from time-matched mocks (CM) were
individually labeled with
18O, and spiked at equal amounts into
the appropriate HCVcc- or UV-HCVcc-inoculated sample for
analysis of protein abundance changes occurring at 24, 48 and
72 h post-infection. In each case a total of 25 mg of the resulting
peptide mixture was subsequently used for pre-MS peptide
separation and quantitative LC-MS peptide analysis as described
in the following sections.
Pre-MS Peptide Separation
Labeled and combined Huh-7.5 peptide samples, total of 25 mg
peptide for each sample, were subjected to strong cation exchange
chromatography (SCX) prior to LC-MS analysis as previously
described [21]. Briefly, samples were suspended in 1.5 ml of
10 mM ammonium formate, 25% acetonitrile, pH 3.0 and
injected onto a 1064.6-mm guard column attached to a
polysulfoethyl A 20064.6-mm (5-mm, 300-A ˚) column (Poly LC,
Columbia, MD). The mobile phases consisted of solvent A
(10 mM ammonium formate, 25% acetonitrile, pH 3.0) and
solvent B (500 mM ammonium formate, 25% acetonitrile,
pH 6.8). The separations were performed using an Agilent 1100
series HPLC system at a flow-rate of 200 mL/min. After sample
loading, the separation was isocratic for 5 min with 100% solvent
A with a flow rate of 1 ml/min. Peptides were eluted using
sequential linear gradients from 100% solvent A to 50% solvent B
over 25 min and from 50% solvent B to 100% solvent B over
another 10 min. The mobile phase was held at 100% solvent B for
another 10 min. A limited number of 5 fractions were collected
and retained for each separation based upon the observed
reproducible chromatographic peaks, lyophilized and analyzed
via reversed-phase LC-MS.
Preparation of Packed Capillary Columns for LC-MS
Peptide and Lipid Analyses
Seventy-five or 150 mm capillary LC columns were slurry-
packed with either 3 or 5 mm Jupiter C18-RP particles
(Phenomenex, Torrance, CA) for peptide and lipid analyses,
respectively, as previously described [22]. Briefly, the stationary
phase was added to a stainless steel reservoir, to which an empty
fused silica capillary (Polymicro Technologies, Phoenix, AZ) was
connected. The opposite end of the capillary was connected to a
stainless steel union (Valco, Houston, TX) containing a stainless
steel screen (either 0.5 or 2 mm mesh for 75 or 150 mm columns,
respectively, Valco) that served as a frit. Acetonitrile was used as
the packing solvent and was delivered at constant pressure by
syringe pump (ISCO, Lincoln, NE). Initially, a pressure of 100 psi
was applied. The pressure was then increased stepwise to and held
constant at 10,000 psi or 7,000 psi for 75 or 150 mm columns,
respectively, for 5–10 min under sonication.
LC-MS Peptide Analysis
Each Huh-7.5 SCX fractionated peptide sample was individ-
ually analyzed using a fully automated custom built capillary LC
system containing four column 75 mm665 cm capillary column
system, as previously described [23]. The capillary LC system was
coupled to a hybrid linear ion-trap-orbitrap (LTQ-Oribitrap,
ThermoFisher, San Jose, CA) and analysis was performed as
previously described [19,20].
LC-MS Lipid Analyses
An automated LC system with two 150 mm665 cm capillary
columns was used. Dried lipid extracts were reconstituted in 75 ml
methanol and vortexed for 10 s. The samples were then
centrifuged at 13,4006g for 5 min to remove any particulates.
Lipid molecular species were chromatographically separated as
previously described [24].
The capillary LC system was coupled to a hybrid linear ion-
trap-Fourier transform ion cyclotron resonance (FTICR) mass
spectrometer (LTQ-FT, ThermoFisher, San Jose, CA). The
capillary temperature and electrospray voltage were 200uC and
+2.2 kV, respectively. The FT was used as the mass analyzer
during MS survey scans over the m/z range 300–2000, with a duty
cycle of ,1.0 s. Data-dependent MS/MS was performed in the
LTQ for the top 5 ions, with a normalized collision energy of 35%.
Dynamic exclusion in the LTQ during data-dependent MS/MS
experiments was enabled as follows: repeat count of 2, repeat
duration of 30 s, exclusion list size of 250, and exclusion duration
of 60 s.
Processing of Peptide and Lipid LC-MS Datasets
Both peptide and lipid LC-MS datasets, defined as the data
obtained from a single LC-MS analysis, were processed using the
PRISM Data Analysis system [25], a series of software tools (e.g.
Decon2LS [26], VIPER [27]; freely available at http://ncrr.pnl.
gov/software/) developed in-house. The first step involved
deisotoping of the raw MS data to give the monoisotopic mass,
charge state, and intensity of the major peaks in each mass
spectrum. The data were next examined in a 2-D fashion to
identify groups of mass spectral peaks that were observed in
sequential spectra using an algorithm that computes a Euclidean
distance in n-dimensional space for combinations of peaks. Each
group, generally ascribed to one detected species and referred to as
a ‘‘feature’’, has a median monoisotopic mass, central normalized
elution time (NET), and abundance estimate computed by
summing the intensities of the MS peaks that comprise the entire
LC-MS feature.
The identities of detected features of both peptides and lipid
LC-MS datasets were initially determined by comparing their
measured monoisotopic masses and NETs to the calculated
monoisotopic masses and observed NETs of each of the peptides
or lipids in an accurate mass and time (AMT) tag database within
search tolerances of 65 ppm and 60.02 NET for monoisotopic
mass and elution time, respectively [24]. The AMT tag database
utilized for peptide matching was a composite of all previous
published Huh-7.5 and human liver tissue MS/MS analyses
Metabolic Reprogramming by HCV
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from human plasma, erythrocyte, and lymphocyte lipids. Non-
linear chromatographic alignment of LC-MS datasets was
performed with the LCMSWARP algorithm [28] during database
matching by using the NETs of either peptide or lipid AMT tags
as retention time locks. The identities of some features that did not
match entries in the lipid AMT tag database were determined
manually based on accurate mass, isotopic distribution (using the
in-house software IsotopicDistributionModeler), and MS/MS
information, as previously described [24].
In regard to peptide data analysis, the abundance ratios
(
18O/
16O) for labeled peptide pairs were accurately computed
using an equation as previously reported [19,29]. All ratios
corresponding to peptide sequences which overlapped between
multiple protein groups, based upon ProteinProphet results [30],
wereremoved as the exactprotein source of thesepeptidesequences
is ambiguous. After rolling-up all remaining quantified peptides into
non-redundant protein groups using the ProteinProphet results, the
corresponding
18O/
16O intensity data was loaded into Rosetta
Elucidator (Rosetta Biosoftware, Seattle, WA) and an error-model
for
18O-labeled FTICR data was applied as previously described
[20]. Ratios from multiple observations of the same protein across
the 5 SCX fractions were then rolled up to compute a final protein
abundance ratio for all proteins identified in a given sample and to
identify those proteins exhibiting statistically significant (p#0.05)
changes in abundance compared to the control sample.
For lipid analysis, after chromatographic alignment and
database matching, intensity normalization was applied using the
expectation maximization algorithm [24]. Briefly, this algorithm
analyzes the histogram of log ratios of intensities of features
common to two or more datasets and finds the peak apex of this
distribution by assuming that the histogram is a mixture of a
normal density corresponding to unchanged features and uniform
density background corresponding to changed features. The
expectation maximization algorithm calculates the normal and
uniform parts of the histogram, and a shift in intensity is applied to
all features in the aligned dataset. It is important to note that all
lipid features (i.e. both identified and unidentified) were considered
during intensity normalization.
The set of normalized lipid features (both identified and
unidentified) was then transformed to log 2 scale and comparative
data analysis was performed on two levels. The first level considered
only complete data, i.e. those lipid features detected in every LC-
MS dataset. The second level allowed for some missing data; a
feature was required to be observed in both LC-MS replicates of
two out of three conditions (mock, HCVcc, and UV-HCVcc). It is
important to note that more observations than the required
minimum were present for most lipid features within a culture
condition. The data matrices corresponding to these two levels were
analyzed separately using Matlab, and changes in the lipid profiles
as functions of time and conditionweredetermined usinganalysis of
variance (ANOVA, p,0.05). Lipid features that were significantly
different by ANOVA were further analyzed using principal
component analysis (PCA) [31]. Abundance values for missing
lipid features were estimated as the average lipid abundance
obtained from the same features observed in the remaining LC-MS
datasets to aid visualization in PCA only. Finally, a table showing
the associated p values, average lipid abundances, lipid abundance
standard deviations, mass-to-charge (m/z) ratio, NET, and lipid
identities were generated and are provided as supplementary data.
Network Generation and Topological Analysis
We generated correlation networks by calculating Pearson
correlation coefficient between the abundance profiles of all pairs of
proteins and/or lipid species. We filtered out relationships between
proteins in which more than two time points did not contain an
abundance measurement in either profile. Human protein-protein
interactions were obtained from http://cytoscape.wodaklab.org/
wiki/Data_Setsandwere filtered to include onlyinteractionsbetween
proteins observed by proteomics. Networks were merged by filtering
at various thresholds and using the union of edges in the ‘parent’
networks to generate the ‘child’ network. Network topology was
calculated using the NetworkX Python module (http://networkx.
lanl.gov/) using betweeness centrality. Bottlenecks were considered
to be the top 20% of proteins/lipids as ranked by betweeness (as in
[32–34]), though all observations were similar using 10% and 5%
thresholds. Statistical significance was calculated using a chi-square
test and p values less than 0.05 were considered significant.
Both the International Protein Index database accession number
(IPI identifier; commonly used for proteomics) and the correspond-
ing EntrezGene identifier are listedherefor eachprotein mentioned
in the text. LRPAP1- IPI00026848, EntrezGene 4043; PEBP1-
IPI00219446, EntrezGene 5037; APOE- IPI00021842, Entrez-
Gene 348; PAFAH1B3- IPI00014808, EntrezGene 5050; ARPC3-
IPI00005162,EntrezGene 10094;CHP- IPI00218136,EntrezGene
11261; VAPA- IPI00170692, EntrezGene 9218; IK- IPI00011875,
EntrezGene 3550; PSMA5- IPI00291922, EntrezGene 5686;
PSME1- IPI00030154, EntrezGene 5720; PSME3- IPI00030243,
EntrezGene 10197; USP39- IPI00419844, EntrezGene 10713;
TPI1- IPI00465028, EntrezGene 7167; LDHA- IPI00217966,
EntrezGene 3939; PKLR- IPI00027165, EntrezGene 5313;
TKT- IPI00021716, EntrezGene 7086; TALDO1- IPI00024102,
EntrezGene 6888; UMP-CMPK- IPI00219953, EntrezGene 129607;
ITPA- IPI00018783, EntrezGene 3704; TS- IPI00103732, Entrez-
Gene 7298; POLD1- IPI00002894, EntrezGene 5424; AK4-
IPI00016568, EntrezGene 205; CS- IPI00025366, EntrezGene
1434; IDI1- IPI00220014, EntrezGene 3422; FABP1- IPI00010292,
EntrezGene 2168; TMEM97- IPI00020004, EntrezGene 27346;
FASN- IPI00418433, EntrezGene 2194; ACOX1- IPI00296907,
EntrezGene 51; DECR1- IPI00003482, EntrezGene 1666; HADH2-
IPI00017726, EntrezGene 3028; DCI- IPI00300567, EntrezGene
1632; ECH1- IPI00550041, EntrezGene 1891; OAT- IPI00022334,
EntrezGene 4942; GLUD1- IPI00016801, EntrezGene 2746; FH-
IPI00296053, EntrezGene 2271; MDH2- IPI00291006, EntrezGene
4191: GOT2- IPI00018206, EntrezGene 2806; IDH2- IPI00011107,
EntrezGene 3418; SOD1- IPI00218733, 6647; PRDX1-
IPI00000874, EntrezGene 5052; TXN- IPI00216298, EntrezGene
7295.
Results
Global Proteome Response to Acute HCV Infection of
Cultured Hepatoma Cells
In order to gain a better understanding of virus-host interactions
during the early phase of acute infection, quantitative proteomic
studies were carried out in Huh-7.5 cells infected with an HCV
cell culture (HCVcc) genotype 2a chimeric virus, J6/JFH-1.
Changes in host protein abundance in HCVcc-infected cells were
compared to cells inoculated with conditioned media (CM) or
exposed to UV-inactivated HCVcc, which cannot undergo
replication. Using
16O/
18O stable isotope labeling together with
the AMT tag approach [20,35], we quantified a total of 2,418
proteins (Supplementary Table S1). Of these, 495 proteins
exhibiting significant abundance changes ($1.5-fold, p#0.05)
between 24–72 h post-infection were analyzed in Spotfire (Spot-
fire, Inc.) using a hierarchical clustering algorithm that allowed
grouping of similar samples based on the pattern of fold-change in
protein abundance (Fig. 1, Supplementary Table S1).
Metabolic Reprogramming by HCV
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ed virus underwent dramatic changes in their proteome that
partially overlapped with the altered protein abundances detected
in HCVcc-infected cells (Fig. 1). These findings suggest that HCV
binding to the hepatocyte plasma membrane induces a host cell
response. Examination of this subset of proteins revealed
conserved increases across a broad range of cellular processes,
indicative of both pro-viral (e.g. lipid/lipoprotein binding and
hydrolysis- LRPAP1, PEBP1, APOE, PAFAH1B3; clathrin-
mediated endocytosis- ARPC3, CHP; tight junction signaling-
VAPA; antagonism of host defenses- IK) and anti-viral (e.g.
ubiquitination and MHC class 1 antigen presentation- PSMA5,
PSME1, PSME3, USP39) activities (Supplementary Table S1).
Despite these similarities, the clustering analysis segregated HCV-
cc and UV-inactivated HCVcc-inoculated cells into two distinct
groups, delineating subsets of proteins that increased in abundance
specifically in response to productive HCV infection (Fig. 1). Since
we were particularly interested in understanding the host processes
that control HCV replication and infectious particle production,
we further explored the biological significance of the HCVcc-
specific subsets using Ingenuity Pathways Analysis (IPA) (Ingenuity
Systems Inc). The results of this functional and canonical pathways
analysis are described in the sections that follow.
HCV Infection Induces an Early Metabolic Re-Routing that
Favors Elevated Host Biosynthetic Activities Important for
the Viral Life Cycle
Overall, the pathway analyses revealed a temporal sequence of
modifications to the host cell proteome reflecting marked
alterations in metabolic homeostasis during virus infection. The
metabolic heat map presented in Figure 2 is a graphic display of
the magnitude of the related protein abundance changes observed
in either HCVcc or UV-inactivated HCVcc-inoculated cells,
demonstrating the limited overlap in commonly regulated
abundance differences. For example, of the 79 proteins represent-
ed here 59 were shown to be statistically significantly up-regulated
($1.5-fold, p#0.05) by infectious HCVcc at 24 h post-infection
(highlighted in red in Supplementary Table S2). This contrasts
with the smaller repertoire of differentially regulated proteins (17
total) observed in the presence of UV-inactivated HCVcc, which
included 11 proteins exhibiting significant decreases in abundance
and only 6 proteins exhibiting significant increases analogous to
those seen with infectious HCVcc (highlighted in green and red in
Supplementary Table S2, respectively). Notably, we detected a
significant increase in the relative abundance of 6 out of 7
glycolytic enzymes in the presence of infectious HCVcc while only
one of these proteins, triose phosphate isomerase 1 (TPI1), was
also observed to be up-regulated in the presence of UV-inactivated
virus (Fig. 2, highlighted in Supplementary Table S2). Our results
indicate that the HCV-infected cell exhibits a unique proteomic
(and metabolic) profile, considerably stimulating increased flux
through the glycolytic pathway.
Analogous to the Warburg effect described for cancer cells and
rapidly proliferating non-transformed cells [36,37], we further
observed proteome changes consistent with a shift toward lactate
production rather than catabolism of glucose via the tricarboxylic
acid (TCA) cycle. The concomitant increase in lactate dehydro-
genase (LDHA; Fig. 2, Supplementary Table S2), is predicted to
divert the majority of glycolytic pyruvate to lactate production and
regeneration of NAD
+ in support of continued glycolysis.
Furthermore, the absence of a significant increase in pyruvate
kinase (PKLR) abundance is expected to favor partitioning of
glucose intermediates to host biosynthetic pathways supporting the
viral life cycle. For example, accumulation of fructose 6-phosphate
and glyceraldehyde 3-phosphate is predicted to promote rerouting
into the pentose phosphate pathway for generation of ribose 5-
phosphate, an important precursor for the synthesis of nucleotides
required for RNA replication. Indeed, high levels of intracellular
uridine triphosphate (UTP) and cytidine triphosphate (CTP) have
been reported to be critical for HCV replication in non-dividing
cells [38]. Consistent with this, we detected an increase in the
relative abundance of non-oxidative pentose phosphate pathway
enzymes, transketolase (TKT) and transaldolase (TALDO1), as
Figure 1. HCV infection induces temporal changes in the host cell proteome. Data from the five strong cation exchange (SCX) fractions
generated and analyzed for each sample were processed and loaded into Rosetta Elucidator (Rosetta Biosoftware Inc.) for error modeling and
computation of final protein abundance ratios. Among 2,418 unique proteins quantified, a total of 495 proteins differentially regulated ($1.5-fold
change, p-value#0.05) in at least two experiments were selected for subsequent cluster analysis. Two-dimensional hierarchical clustering was
performed with a weighted average method and Cosine correlation metric. Each horizontal row represents an individual infection condition and each
vertical column an individual protein (495 total). Abundance ratios were monitored 24, 48 and 72 h after infection with either HCVcc (chimeric HCV 2a
virus, J6/JFH-1) or UV-HCVcc (UV-inactivated chimeric HCV 2a virus, J6/JFH-1) and using a time-matched mock (conditioned media, CM) as the
reference. Protein abundance ratios are colored according to the fold changes and the color scale indicates the magnitude of fold change. Black
squares indicate no change in protein abundance. Gray squares indicate missing data.
doi:10.1371/journal.ppat.1000719.g001
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and homeostasis [e.g. UMP-CMP kinase (UMP-CMPK), inosine
triphosphate pyrophosphatase (ITPA), thymidylate synthase (TS),
DNA polymerase delta catalytic subunit (POLD1), and adenylate
kinase isoenzyme 4 (AK4)] (Fig. 2, Supplementary Table S2).
Although our results suggested HCV-infected cells exhibit a
Warburg effect, we also observed a coordinated increase in the
abundance of TCA cycle enzymes, as well as of numerous
components of the electron transport chain and ATP-synthesizing
proton pump, indicating that oxidative glucose metabolism
Figure 2. HCV induces perturbations in metabolic homeostasis. The 495 differentially regulated proteins described in Figure 1 were subjected to
functional and canonical pathwayanalysis using Ingenuity Pathways Analysis (Ingenuity Systems Inc). Shown here is a metabolic map illustrating thed y n am i c
changes in host biosynthetic and catabolic pathways occurring during HCV infection. Each horizontal row represents a differentially regulated protein
identified by its gene symbol and each vertical column represents an individual infection condition. Abundance ratios for the various samples appear in the
following order fromleft to right: infection with HCVcc at 24, 48 and 72 h (columns 1, 2, and 3, respectively) or UV-HCVcc at24, 48and 72 h (columns 4, 5, and
6, respectively). Protein abundance ratios are colored according to the fold changes and the color scale indicates the magnitude of fold change. Black squares
indicate no change in protein abundance. Gray squares indicate missing data. HCV infection induces a unique proteomic profile indicative of marked
disruptions incellularmetabolic homeostasis.The limitedoverlap, andin some cases magnitude, of protein up-regulation in actively growing cellsex po se dt o
UV-inactivated virus further suggests that infectious HCVcc specifically institutes its own metabolic program by considerably stimulating host biosynthetic
activities supporting viral growth. See text and Supplementary Table S2 for more detail including correlation of gene symbol with protein name.
doi:10.1371/journal.ppat.1000719.g002
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conditions of sufficiently high glycolytic flux it is likely that some
pyruvate is converted to acetyl-CoA and enters the TCA cycle
even without a necessarily coordinate increase in PDH levels. The
collective up-regulation of citrate synthase (CS) and various
lipogenic proteins [e.g. isopentenyl-diphosphate delta isomerase
1 (IDI1), fatty acid binding protein 1 (FABP1), MAC30 protein
(TMEM97), and fatty acid synthase (FASN)] 24 h after infection
suggests that TCA cycle activity is coupled with the generation of
cytosolic citrate for fatty acid synthesis, producing lipid species to
support the viral life cycle (Fig. 2, Supplementary Table S2).
Interestingly, we observed that the up-regulation of lipogenic
enzymes was paralleled by increased abundance of proteins
associated with peroxisomal and mitochondrial fatty acid oxida-
tion [e.g. acyl-CoA oxidase 1 (ACOX1), 2,4-dienoyl-CoA
reductase (DECR1), 3-hydroxyacyl-CoA dehydrogenase type II
(HADH2), 3,2-trans-enoyl-CoA iosmerase (DCI),and ECH1
protein (ECH1)], suggesting active lipid synthesis and turnover
(Fig. 2, Supplementary Table S2).
A final point worth addressing is the variation in magnitude of
protein abundance changes observed here. It is reasonable to
assume that the magnitude of abundance differences may provide
an important perspective for biological interpretation and it is
therefore not surprising that among the larger abundance increases
wedetected werethosefornucleotideandlipidbiosyntheticproteins
of predicted importance to the viral life cycle (e.g. UMP-CMPK,
ITPA, IDI1, and FABP1) (Fig. 2, Supplementary Table S2).
However, we would like to emphasize that it is not clear to what
extent protein abundance must be altered to exact a biologically
relevant consequence. In this regard, the coordinate up-regulation,
albeit to a lesser extent (,1.5–3.0 fold change), of a majority of the
enzymes in the glycolytic, non-oxidative pentose phosphate, and
TCA pathways provides increased confidence in the significance of
these protein abundance changes and their relative functional
importance to HCV infection.
Early Metabolic Re-Routing is Accompanied by
Anaplerotic Reactions that Replenish Metabolic
Intermediates and Sustain Macromolecule Biosynthesis
In order to ensure continued TCA cycle function in macromo-
lecular biosynthesis, cells must replenish the pools of metabolic
intermediates (anaplerosis) depleted during lipid, protein, and
nucleic acid synthesis [36,39]. For example, citrate export
supporting lipid synthesis (e.g. fatty acid, cholesterol, and isopren-
oids) results in a concomitant decline in oxaloacetate (OAA) from
the TCA cycle, which must be replenished for further citrate
production and lipogenesis to occur. Our proteomic data indicates
that HCV-infected cells exhibit increased levels of several proteins
involved in replenishing metabolic intermediates of the TCA cycle,
including pyruvate carboxylase (PC), the major anaplerotic
mitochondrial enzyme that generates OAA directly from pyruvate.
Inaddition,wedetected up-regulationofseveralenzymescatalyzing
interconversion of ornithine, proline, and glutamate, suggesting that
glutamine metabolism provides an alternative source of anaplerotic
substrates (Fig. 2, Supplementary Table S2). This increased
abundance of enzymes catalyzing glutamine flux through the latter
half of the TCA cycle [e.g. ornithine aminotransferase (OAT),
glutamate dehydrogenase (GLUD1), fumarate hydratase (FH), and
mitochondrial malate dehydrogenase (MDH2)] provides substrates
for ATP production while simultaneously replenishing OAA for
biosynthesis. The further accumulation of aspartate aminotransfer-
ase (GOT2) suggests that a portion of the anaplerotic source of
OAA is utilized for generating aspartate, a required precursor for
nucleotide synthesis. Finally, the increased abundance of NADP-
dependent isocitrate dehydrogenase (IDH2), an enzyme known
to catalyze reductive carboxylation of glutamine and reverse TCA
flux from a-ketoglutarate to citrate [40], suggests that glutamine
metabolism may further contribute to anaplerosis by providing an
alternative source of lipogenic acetyl-CoA.
Acute HCV Infection is Associated with an Early Induction
of Proteins Functioning in Cellular Stress Responses
Consistent with previous reports [20,41], we detected an early
(24 h post-infection) induction of chaperone proteins and
numerous components of the NF-E2-related factor-2 (Nrf2)-
mediated oxidative stress response, providing evidence for
endoplasmic reticulum (ER)/oxidative stress during acute infec-
tion of cultured Huh-7.5 cells (Fig. 3, Supplementary Table S2).
Among the up-regulated antioxidant proteins were members of the
reactive oxygen species (ROS) stress response [e.g. superoxide
dismutase (SOD1) and peroxiredoxin 1 (PRDX1)] as well as
proteins involved in maintaining the redox state of the cell [e.g.
thioredoxin (TXN), various glutathione S transferases (GSTs)]. An
accompanying increase in the abundance of numerous proteins
functioning in translation initiation is in line with previous reports
describing high levels of HCV and cellular protein synthesis
despite the presence of ER stress (Supplementary Table S1)
[41,42].
Remodeling of Metabolic Pathways Reflects a Shift from
Synthetic to Energetic Purposes as Infection Progresses
Evaluation of later time points revealed that the increased
abundance of fatty acid oxidation, amino acid catabolism, and
TCA cycle enzymes was sustained 48 h after infection (Fig. 2,
Supplementary Table S2). In stark contrast, the early up-
regulation of proteins functioning in glycolysis, oxidative phos-
phorylation, and macromolecular biosynthesis was dramatically
abated, suggesting a metabolic shift toward amino acid and fatty
acid utilization for energy purposes through the TCA cycle. A
similar metabolic phenomenon has been described for HepG2
cells, where rapidly proliferating (subconfluent) cells generate
energy via glucose consumption and lactate production, along with
de novo macromolecule synthesis, while growth arrested (confluent)
cells exhibit increased amino acid flux through the TCA cycle
[43]. Interestingly, our previously reported gene expression
analyses, which were carried out in parallel with the current
proteomic and lipidomic studies, demonstrated that HCV
infection is associated with a progressive increase in the number
of differentially regulated cell cycle checkpoint/arrest genes [17].
Subsequent flow cytometry analyses confirmed a decline in entry
into S phase for infected cells [17]. Taken together, these findings
suggest that HCV infection is associated with a delay in cell cycle
progression that is accompanied by an adaptive metabolic
response aimed at channeling substrates from synthetic to
energetic purposes.
Review of the proteomic data at 72 h post-infection suggests a
partial re-emergence of glycolytic and biosynthetic activities (Fig. 2,
Supplementary Table S2). In this regard, we note that, despite our
best efforts to obtain a high efficiency of infection, these cultures
are characterized by asynchronous replication and we suspect that
this re-emerging pattern reflects spread of infection.
Alterations in Metabolic Homeostasis Occur During HCV
Infection in Patients
We have previously reported the global proteomic alterations
accompanying liver disease progression in patients chronically
infected with HCV [20]. To determine the clinical relevance of the
Metabolic Reprogramming by HCV
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cells, we compared the in vitro proteome data with the 210
clinically identified proteins exhibiting statistically significant
(ANOVA) differences associated with fibrosis stage [20]. A subset
of the carbohydrate, amino acid, and lipid metabolism proteins
that were up-regulated early during HCV infection in cell culture
(e.g. 24 h post-infection) were also up-regulated in chronically
infected individuals with no or minimal liver disease (e.g. fibrosis
Figure 3. HCV induces protein abundance changes indicative of endoplasmic reticulum (ER) stress and oxidative stress during
acute infection of cultured Huh-7.5 cells. Each horizontal row represents a differentially regulated protein identified by its gene symbol and each
vertical column represents an individual HCV infection time point. Abundance ratios for the various samples appear in the following order from left to
right: infection with HCVcc at 24, 48 and 72 h (columns 1, 2, and 3, respectively) or UV-HCVcc at 24, 48 and 72 h (columns 4, 5, and 6, respectively).
Protein abundance ratios are colored according to the fold changes and the color scale indicates the magnitude of fold change. Black squares indicate
no change in protein abundance. Gray squares indicate missing data. Refer to Supplementary Table S2 for more detail including correlation of gene
symbol with protein name.
doi:10.1371/journal.ppat.1000719.g003
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declines in fatty acid catabolism and oxidative stress responses
evident at later times during HCV infection in cell culture (e.g.
72 h post-infection) coincide with similar decreases during liver
disease progression in vivo (Fig. 4). These findings suggest that the
proteome alterations in HCVcc-infected Huh-7.5 cells parallel
those occurring during natural infection in vivo, reinforcing the
utility of the in vitro system for investigating the mechanisms by
which HCV modulates host cell metabolism and the interplay
between altered cellular metabolic homeostasis and liver disease
progression.
Acute HCV Infection Induces Temporal Changes in the
Host Cell Lipidome
The documented role of lipids in HCV infection, as well as the
extensive changes in lipid metabolism predicted from our global
proteome measurements, suggested significant impacts on the
infected cell lipidome. We therefore conducted LC-MS-based
studies to define the lipid profiles of HCVcc-infected Huh-7.5
cells, as well as cells exposed to CM or UV-inactivated virus, over
time. Normalized abundances were averaged within respective
replicates and statistical analysis was performed to identify 272
lipids with differential expression across conditions and time points
Figure 4. Common regulation of protein abundance changes in HCV-infected Huh-7.5 cells and patient liver tissue. Each horizontal
row represents a differentially regulated protein identified by its gene symbol. Each vertical column represents an individual sample. Abundance ratios
for the various samples appear in the following order from left to right: cultured hepatoma cells infected with HCVcc at 24, 48 and 72 h, cultured
hepatoma cells exposed to UV-HCVcc at 24, 48 and 72 h, and then patients chronically infected with HCV and exhibiting stage 0 (F0), stage 1 (F1),
stage 2 (F2), stage 3 (F3) or stage 4 (F4) fibrosis [20]. Protein abundance ratios are colored according to the fold changes and the color scale indicates
the magnitude of fold change. Black squares indicate no change in protein abundance. Gray squares indicate missing data. Protein abundance
information for HCVcc-infected Huh-7.5 cells can be found in Supplementary Table S2 and for human liver biopsy specimens in [20].
doi:10.1371/journal.ppat.1000719.g004
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were further identified by matching to a lipid AMT tag database
or by targeted MS/MS analysis (Supplementary Table S3).
Subsequent comparison using principal components analysis
(PCA) allowed the evaluation of trends or patterns across
treatment conditions and time points (Fig. 5). Briefly, the greater
the influence of time (principal component 1) or infection
inoculum (principal component 2) on quantitative differences in
the lipid profiles, the greater the segregation of samples on the
respective axis. The resulting scores plot demonstrates a greater
separation along principal component 2 for HCVcc-infected
samples relative to time-matched mock or UV-HCVcc inoculated
controls (Fig. 5), suggesting dramatic changes in the quantitative
lipid profile of cells undergoing productive infection. The further
segregation of samples along principal component 1 suggests that
additional differences in the lipidome occur as infection progresses.
Consistent with the increased lipogenic activity predicted from
our proteome analyses, lipidome analyses revealed a progressive
accumulation of several phosphatidylcholine (PC) and phosphati-
dylethanolamine (PE) species (Supplementary Table S3) that
parallels the peak in viral replication observed 72 h post-infection
[17]. Representative examples are presented in Figure 6 where the
phosphatidylcholine species PC 30:0 (panel A) and the phospha-
tidylethanolamine species PE 35:0 (panel B) are shown to exhibit
increased abundances in the HCVcc samples (red bars) at 48 and
72 hours post-infection relative to either the mock (black bars) or
UV-inactivated HCVcc (blue bars) samples. These data support a
role for lipid species in the viral life cycle, perhaps in the formation
of cytosolic lipid droplets and modified membrane compartments
for promotion of replication and infectious virus assembly [6–13].
Consistent with this, several of the up-regulated proteins identified
by the proteomics analysis have been previously detected in
purified membrane vesicles containing HCV replication complex-
es [e.g. N-ethylmaleimide-sensitive factor (NAPG), syntaxin 7
(STX7), annexin A4+A5 (ANXA4+ANXA5), vesicle-associated
membrane protein-associated protein B/C (VAPB), peroxisomal
enoyl CoA hydratase 1 (ECH1), mitochondrial trifunctional
protein (HADHB), NAD(P) dependent steroid dehydrogenase-like
(NSDHL)] (Supplementary Table S1) [12].
While some phosphatidylcholine and phosphatidylethanol-
amine species accumulated during infection, others exhibited a
progressive decline in abundance during the course of the HCV
life cycle. These included PC 35:1 and PE 38:3 whose abundance
in HCVcc samples (red bars) decreased over time relative to either
mock (black bars) or UV-inactivated HCVcc samples (blue bars)
(Fig. 6C and D, respectively). Similar HCVcc-associated temporal
abundance decreases were observed within other lipid classes
including cholesterol esters (e.g. CE 20:5, Fig. 7A), triacyglycerols
(e.g. TAG 56:8, Fig. 7B) and sphingomyelins (e.g. SM (d16:1/24:1)
and SM (d18:1/24:1), Fig. 7C and D, respectively). These
temporal decreases appear to parallel the accumulation of
extracellular infectious virions (Fig. 8), suggesting potential
consumption of these lipids in the closely linked processes of very
low density lipoprotein (VLDL) and HCV assembly and secretion.
Alternatively, the decline in certain sphingomyelin species (e.g. SM
(d18:1/24:1), Fig.7D) may be explained by their utilization as
precursors for the synthesis of reactive ceramides exhibiting
concomitant increases in abundance (e.g. Cer (d18:1/24:1),
Fig. 7F). Ceramides have been shown to play an important role
in plasma membrane organization, thereby modulating a variety
of cellular processes including apoptosis and endocytosis [44,45].
Our previously reported global transcriptional profiling of infected
Huh-7.5 cells demonstrated that HCVcc may mediate direct
cytopathic effects through perturbation of the cell cycle, and that
this process may contribute to liver disease progression [17]. The
increased abundance of lipotoxic, pro-apoptotic ceramides
detected here suggests a previously undescribed link between lipid
metabolism and the cytopathic effect [17]. Interestingly, a similar
phenomenon has been described in the pathogenesis of Wilson’s
disease, where copper-induced activation of acid sphingomyelinase
results in the accumulation of reactive ceramide species that
trigger hepatocyte death and promote fibrogenesis [44]. Alterna-
tively, increased abundance of ceramides may reflect an adaptive
host response aimed at minimizing the spread of infection, as
ceramides have been reported to have an inhibitory effect on
HCV entry [45].
Novel Protein and Lipid Bottlenecks Identified by
Computational Modeling Efforts are Important for
HCV-Associated Metabolic Reprogramming
We and others have previously described methods of identifying
important genes or proteins based on topological analysis of
protein-protein interaction (PPI) and inferred networks [32–34]. In
this approach, connectivity of proteins or genes in biological
networks can provide insight into their relative importance.
Briefly, protein or gene ‘‘hubs’’ exhibiting a high degree of
connectivity (e.g. connected to many other proteins or genes) and
‘‘bottlenecks’’ exhibiting a high betweeness (e.g. key connectors of
sub-networks within a network) represent central points for
controlling communication within a network and tend to play
an essential role in growth, virulence and targeting by pathogens.
Here we constructed a protein association network based on
correlations between protein abundance such that proteins
Figure 5. Principal components analysis scores plot showing
the segregation of samples based on lipid profiles. Duplicate
lipid abundance measurements (corresponding to R1 and R2) were
made 24, 48 and 72 h after infection with either HCVcc or UV-HCVcc
and using a time-matched mock (conditioned media, CM) as the
reference. A total of 272 features significantly different (ANOVA,
p,0.05) between treatment and time were compared using principal
components analysis (PCA). The scores plot shows temporal differences
(represented along principal component 1) as well as HCV-specific
differences (represented along principal component 2).
doi:10.1371/journal.ppat.1000719.g005
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PLoS Pathogens | www.plospathogens.org 10 January 2010 | Volume 6 | Issue 1 | e1000719Figure 6. Representative examples of phospholipid species differentially regulated during HCV infection. The relative ion intensity, log
2 scale, and standard deviation is plotted for various phosphatidylcholine (PC) and phosphatidylethanolamine (PE) species monitored 24, 48 and 72 h
after infection with either HCVcc (red bars) or UV-HCVcc (blue bars) and using a time-matched mock (conditioned media, CM; black bars) as the
reference. Panels A-D (lipid species PC 30:0, PE 35:0, PC 35:1, and PE 38:3, respectively) provide examples of phospholipid species exhibiting notable
changes in abundance during the course of HCV infection. Temporal lipid abundance changes conserved across treatment conditions, panels E and F
(lipid species PC 32:2 and PC 34:3, respectively), demonstrate the specificity of those perturbations attributed to HCV infection. See Supplementary
Table S3 for a complete listing of the lipid features detected in this study.
doi:10.1371/journal.ppat.1000719.g006
Metabolic Reprogramming by HCV
PLoS Pathogens | www.plospathogens.org 11 January 2010 | Volume 6 | Issue 1 | e1000719Figure 7. Representative examples of additional major lipid classes differentially regulated during HCV infection. The relative ion
intensity, log 2 scale, and standard deviation is plotted for various other lipid classes monitored 24, 48 and 72 h after infection with either HCVcc (red
bars) or UV-HCVcc (blue bars) and using a time-matched mock (conditioned media, CM; black bars) as the reference. Panels A-D provide examples of
HCV-associated decreases in the relative abundance of cholesterol ester (CE 20:5), triacylglycerol (TAG 56:8), and sphingomyelin (SM (d16:1/24:1) and
SM (d18:1/24:1)) species, respectively. This contrasts with the HCV-associated increase in relative abundance of lipotoxic ceramide (CER) species
shown in panels E and F (Cer (d18:1/24:0) and Cer (d18:1/24:1)), respectively. See legend of Figure 5 for details on the experiment representation and
Supplementary Table S3 for a complete listing of the lipid features detected in this study.
doi:10.1371/journal.ppat.1000719.g007
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the network. We then used the interaction of host proteins with
HCV proteins (as determined in IMAP, [46]) as a measure of
importance. That is, proteins which are documented targets of
direct action by HCV can be considered more important to the
process of infection than those with no known viral associations.
The statistical enrichment of hub and bottleneck proteins in
known HCV targets was determined using a chi-square test. We
found that both bottleneck and hub proteins were significantly
enriched in HCV targets, showing 2–3 fold enrichment depending
on the correlation threshold used for network generation. These
computationally revealed proteins were representative of pathways
known to be perturbed by HCV, including cholesterol transport,
antigen processing and presentation, as well as cell cycle regulation
and cell death, further suggesting the validity of this approach. We
next integrated the abundance correlation networks with known
PPIs, producing a master network of connected cellular processes
at multiple levels. This integrated network displays a greater
enrichment of HCV targets in bottlenecks and hubs than either of
the ‘parent’ networks, and thus identifies more targets with a
greater accuracy (Fig. 9). We then integrated the lipidomics
profiles into this network using the same correlation approach.
Briefly, we calculated the Pearson correlation between the
abundance profile of each identified lipid species with a matched
profile from each protein. Incorporation of lipids into the
integrated network (Fig. 9, circles) improved the number of
HCV protein targets identified slightly but, importantly, did not
decrease the ability of topological features to identify targets.
This analysis provides a number of interesting predictions of
important proteins in the host response to HCV infection. Major
bottleneck nodes (proteins or lipids) are listed in Supplementary
Table S4, and a representative example of an integrated network
surrounding several key bottlenecks is shown in Figure 10. Among
the bottlenecks are several differentially regulated phospholipids
(e.g. PC 30:0 and PE 38:3) and two fatty acid oxidation enzymes
(HADHB and DCI) (Fig. 10) that were seen to be differentially
regulated both in culture and in HCV-infected patients (Fig. 4).
Notably, an apparent decline in the relative abundance of these
enzymes coincided with the appearance of a cytopathic effect in
vitro (e.g. 72 h post infection) and the appearance of significant
liver injury in patients chronically infected with HCV (e.g. stage
3–4 fibrosis). These findings suggest that HCV-associated targeting
of mitochondrial fatty acid oxidation enzymes may contribute to
the temporal alterations in cellular metabolic homeostasis that
occur during infection and to the impairment of key mitochondrial
processes associated with HCV pathogenesis [20].
Discussion
The increasing availability and application of high-throughput
methodologies for gene, protein and metabolite profiling is
beginning to provide considerable insight into how viruses
modulate intracellular host metabolism in order to meet the needs
of the virus growth cycle. For example, a series of elegant studies
integrating mRNA expression profiles with intracellular metabolite
concentrations demonstrated that human cytomegalovirus
(HCMV) institutes its own metabolic program, in part by virus-
induced transcriptional changes that modulate the accumulation
of select glycolytic and TCA intermediates [47]. Subsequent global
kinetic flux measurements revealed a massive up-regulation of
nucleotide and fatty acid biosynthetic reactions [48]. Further
investigation of this unanticipated increase in fatty acid biosyn-
thesis led to the demonstration that viral replication could be
decreased by a pharmacologic inhibitor of acetyl-coenyzme A
carboxylase, the enzyme catalyzing the committed step in fatty
acid synthesis [48]. Similar metabolic perturbations have been
observed in HIV-1-infected cells [49-51], where viral-induced
reprogramming appears to partition glucose and TCA interme-
diates toward biosynthetic reactions, supporting, for example, the
increased cholesterol production previously predicted by gene
expression analyses and confirmed by metabolic labeling studies
Figure 8. Production of infectious HCV in cell culture. Limiting
dilution assays were performed to quantify the amount of infectious
HCVcc particles in the cell culture supernatant, measured as 50% tissue
culture infectious dose per milliliter (TCID50/ml). HCV infectivity
accumulated until 72 h, after which a decline occurred that parallels
the previously described decrease in HCV RNA levels [17]. The reason
for these decreases is unclear, but may be related to a decrease in the
number of cells capable of producing high levels of virus.
doi:10.1371/journal.ppat.1000719.g008
Figure 9. Integration of different network types improves
identification of important nodes in HCV infection. Topology of
the networks was calculated to identify topological bottlenecks, which
were then evaluated for statistical enrichment in proteins known to be
targets of HCV proteins by IMAP [46]. The number of identified targets
(X axis) is shown against the overall fold enrichment of targets in
bottlenecks relative to the rest of the network. The results show that
integrating different networks improves the ability to detect these
important proteins, and implies that bottlenecks not known to be direct
targets of HCV might be playing important roles in the host response
process. The networks are: PPI, human protein-protein interactions
limited to those between proteins identified by proteomics; Proteomics,
correlation-based network from proteomics abundance data; Proteo-
mics-PPI, combined network of proteomics and PPI networks;
Proteomics-Lip, combined network of proteomics and lipidomics;
Prot-PPI-Lip, combined network of proteomics, PPI and lipidomics.
doi:10.1371/journal.ppat.1000719.g009
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tary transcriptome and proteome studies in investigating virus-
induced metabolic changes, and highlight the potential of such
studies to elucidate the mechanisms by which viruses usurp cellular
metabolic resources and to uncover new avenues/targets for drug
discovery.
Here we describe global proteomic and metabolomic profiling
studies that provide insight into the metabolic interplay occurring
during infection of cultured human hepatoma cells with HCV. Our
results indicate that a sequence of protein and lipid abundance
changes during the acute phase of HCV infection reflects a
disruption of normal metabolic homeostasis, and a shift from energy
consuming to energy conserving activities over time. HCV initially
reprograms the cell to favor increased glucose fermentation and the
partitioning of glycolytic intermediates toward the synthesis of
cellular metabolites supporting the viral life cycle. Proteins
functioning in oxidative phosphorylation, including components
of respiratory complexes I and IV and the proton pump, were also
detected. While this finding would seem to contradict a previously
reported HCV-mediated impairment of oxidative phosphorylation
and accompanying dependence on glucose [53], it is possible that
the increased protein abundances observed here reflect a compen-
satory response. We suspect, however, that the electron transport
chain remains at least partially intact, as HCV-infected cells show
detectable ATP production from a carbohydrate source requiring
oxidative phosphorylation, and limited increases in complex III and
IV activity occur even during HCV-associated glucose dependence
[53]. Oxidative phosphorylation may elicit lower levels of ATP
production not only as a result of impaired mitochondrial
respiration per se, but also due to the diversion of TCA cycle
substrates towards elevated macromolecular biosynthesis during
this early phase of infection. Collectively, these findings suggest
that HCV-associated glucose dependence may reflect a specific
metabolic reprogramming aimed at benefiting both energetic and
biosynthetic needs. An analogous situation has been described for
cancer cells, where high glycolytic rates occurring in the presence or
absence of oxidative metabolism offer the potential for sufficient
ATP production while simultaneously providing the cell with
intermediates for macromolecular biosynthesis [36,54].
The trend favoring biosynthesis early in HCV infection was
somewhat surprisingly accompanied by an increase in fatty acid
oxidation at 24 h. While increased malonyl-CoA, a product of
lipogenesis, is expected to impair the uptake of long chain fatty
acids via inhibition of carnitine palmitoyl transfersase 1 (CPT1),
and thus attenuate fatty acid oxidation, differential regulation of
lipogenesis and oxidation can occur through separate pools of
malonyl-CoA in the cytosol and mitochondria, respectively [55].
While the relevance of this simultaneous induction in lipid
synthesis and catabolism during early HCV infection remains to
be determined, we can envision several potential scenarios. Acetyl-
CoA produced from fatty acid catabolism may fuel the generation
of a new pool of fatty acids populated by constituents essential to
the viral life cycle. Alternatively, fatty acid oxidation may be
important in maintaining elevated cellular ATP levels supporting
Figure 10. The integrated network surrounding several key bottlenecks identified by computational modeling efforts. The neighbors
of bottlenecks in the integrated network (DCI, HADHB, PC 30:0, PE 38:3, and PE 38:6) are shown. Relationships between the proteins and lipid species
are grey for proteomics correlation, purple for lipidomics-proteomics correlation, black for protein-protein interactions and red for IMAP relationships.
Lipid species are indicated as green diamonds, HCV proteins are red, mitochondrial proteins are squares, and proteins involved in fatty acid b-
oxidation are in black.
doi:10.1371/journal.ppat.1000719.g010
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phenomenon of increased glucose utilization, de novo lipogenesis,
and active fatty acid oxidation has been described as part of the
thermogenic process in brown adipose and other insulin-sensitive
tissues, such as skeletal muscle [56,57]. Substrate cycling between
lipogenesis and lipid oxidation represents a mechanism for
protecting muscle tissue against lipotoxicity and glucolipotoxicity
[57], and may similarly protect the hepatocyte/liver against the
toxic effects of lipid overload, including insulin resistance and
lipid-induced cell death. This early induction of fatty acid
oxidation may limit the accumulation of ceramide, the appearance
of which correlated with HCV-dependent cytopathic effects later
in infection [17].
At 48 h post-infection, we observed a decline in the relative
abundance of glycolytic enzymes,which apparently reduces macro-
molecular synthesis and renders the cell dependent on alternative
energy sources as infection progresses. This decreased glucose
utilization is consistent with the recent report that HCV replication
suppresses cellular glucose uptake via down-regulation of cell
surfaceglucosetransporters[58].Hostinflammatoryresponseshave
been suggested to mediate this effect [58], which is temporally
consistent with our previous observation of pro-inflammatory
cytokine gene induction [17]. Our failure to detect the resultant
protein products presumably reflects their secretion into the cell
culture supernatant. The sustained up-regulation of fatty acid and
amino acid catabolism appears to account for energy production at
this stage of infection, and this switch may channel substrates from
synthetic to energetic purposes in the wake of increasing cellular
stress. Previous studies have demonstrated that HCV-induced ER
stress results in the release of Ca
++, which can then be transported
into mitochondria [53]. This increased recycling of calcium, which
coincides with maximum viral protein expression [17,53], elicits a
decrease in mitochondrial membrane potential, elevated reactive
nitrogen and oxygen species, and inhibition of respiratory activity
[53]. The resulting decline in ATP production necessitates
compensatory shifts in an effort to maintain energy homeostasis
and cell viability, negatively impacting high-energy processes like
lipid, nucleotide and protein synthesis. Consistent with this, our
proteomic data demonstrated that the initial increases in translation
initiation factors and biosynthetic enzymes was dramatically abated
at 48 h. Despite attempts to maintain homeostasis, it is likely that a
significant energetic deficit occurs during the elevated viral
replication, which, together with oxidative stress, may contribute
to the adverse effects of HCV infection on cell proliferation and
viability [17].
The protein abundance changes described in this study were
typically not accompanied by concomitant gene expression
changes, stressing the importance of post-transcriptional regulato-
ry mechanisms during HCV infection [17,35]. It is interesting to
note that, while virus infection is often associated with a global
attenuation of host cell translation, HCV-associated impairment of
translation initiation factor eIF2a phosphorylation appears to
instead increase overall protein synthesis [41,42,59]. The molec-
ular basis for selective up-regulation of proteins functioning in
metabolic reconfiguration, however, remains to be defined.
Interestingly, recent studies have identified an important role for
miR-122, the predominant microRNA (miRNA) in liver and Huh-
7.5 cells, in regulating lipid metabolism [60,61]. Antisense-
mediated antagonism of miR-122 was shown to decrease fatty
acid and cholesterol synthesis, while fatty acid oxidation rates
increased, thus favoring a switch to an energy-generating state
[61]. Although these changes were attributed to a mild down-
regulation (typically less than twofold) of mRNA, the interplay
between miRNA abundance and miRNA-mediated mRNA
degradation and translational repression is not well understood,
and the effects of miR-122 antagonism on translational regulation
were not evaluated. It is possible that post-transcriptional
mechanisms involving miR-122 contribute to similar alterations
in metabolic phenotype during HCV infection. In this regard,
miR-122 is known to bind the 59 UTR of HCV RNA and enhance
replication [62]. Increasing intracellular HCV RNA concentra-
tions may therefore result in sequestration and progressive
depletion of miR-122, thereby interfering with lipogenesis and
contributing to the reprogramming of hepatocellular metabolism
and bioenergetics. Although our steady-state measurements do not
allow us to distinguish between perturbations in protein stability
and protein synthesis, the recent development of new proteomic
approaches, such as pulsed stable isotope labeling with amino
acids in cell culture; pSILAC, offers opportunities to evaluate the
contribution of translational regulation to HCV-associated
changes in the host proteome [63].
Differential regulation of a variety of lipid species was predicted
by our proteome studies and subsequently confirmed by lipidomic
analyses. The increased abundance of select phospholipids may
reflect their role as important constituents in the various structural
entities supporting viral replication, including the lipid droplet and
membranous replicase compartments. In contrast, the decline in
other phospholipid species and lipid classes (e.g. sphingomyelin,
triacylglycerol) may reflect their incorporation into lipoprotein
associated viral particles and potentially important roles in
infectivity. Although HCV-associated cholesterol and sphingolipid
have been shown to play a critical role in infection [16], the precise
virion lipid composition, including molecular species of each class
and relationship to virion maturation, is unknown. Recent mass
spectrometry based analyses of the HIV lipidome have identified a
broad repertoire of lipids within the virion [16,64], as well as
highlighted a key role for raft-like microdomains in virion budding
and identified select phosphatidylserine species, which may
represent viable therapeutic targets for modulating membrane
composition and infectivity [64,65]. Our studies of HCV-infected
cells provide a valuable reference for use dissecting the role of
various host cell lipid species in the viral life cycle.
Insummary, theresultsofourintegrative genomicsefforts provide
new clues for understanding the role of metabolic reprogramming
duringtheacutephaseofHCVinfection.Thisstudyisuniqueinthat
it provides the first demonstration of profound modifications in the
proteome indicating that a temporal sequence of metabolic
alterations occurs during HCV infection, and describes a previously
un-identified key role for post-transcriptional regulatory mechanisms
in this metabolic re-routing. Significantly, the presence of metabolic
perturbations was confirmed by measurement of lipid metabolite
levels. Concomitant increases in intracellular lipids and viral loads
were observed to occur subsequent to the early induction of multiple
lipogenic proteins, including enzymes [e.g. acetyl coa carboxylase
(ACAA) and fatty acid synthase (FASN)] whose pharmacologic
inhibition was previously shown to hinder HCV replication in a
stable HCV full-length replicon system [66]. Taken together, we
believe that these observations provide ‘‘proof of principle’’ for the
utility of integrative functional genomics studies to shed new light on
processes of functional significance during HCV infection and
pathogenesis.
Typical of high-throughput functional genomics studies, our
global proteome and lipidome analyses have led to many new and
interesting hypotheses that warrant further investigation. A major
challenge in translational hepatology research is to integrate the
vast amounts of data collected from these high-throughput
approaches into a single systems-level view that allows identifica-
tion and prioritization of potential targets for novel antiviral
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tional modeling approaches to begin constructing a molecular
interaction network that describes key components and interac-
tions associated with HCV infection. These efforts have led to
several novel observations, including the identification of two
mitochondrial fatty acid oxidation enzymes, trifunctional enzyme
b subunit (HADHB) and 3,2-trans-enoyl-CoA isomerase (DCI), as
network bottlenecks predicted to play a key regulatory role in
HCV-associated metabolic reprogramming. Interestingly, the
modulation of fatty acid oxidation has been linked to the
suppression of virus replication and reduction of cytopathic effects
in an in vitro model of persistent measles virus infection, and a
potential role in evasion of the immune response has been
suggested [67]. To further investigate the role of HADHB and
DCI in the HCV life cycle we are now employing standard RNA
interference (RNAi) methods to generate stable shRNA knock-
down clones in retinoic acid-induced gene 1 (RIG-I) competent
Huh7 cells as well as Huh-7.5 cells in order to evaluate the impact
on virus replication, assembly and secretion. Observation of a
phenotypic effect would open the door to several new and exciting
avenues of investigation, including further exploration of a
potential mechanism involving interactions between viral replica-
tion, fatty acid oxidation and host innate immune responses in the
establishment of chronic HCV infection. The results of such
studies will also facilitate efforts to link clinical functional genomics
profiles with pathway-specific signaling and gene/protein/metab-
olite expression and function. Finally, these phenotypic perturba-
tions would provide a starting point for exacting the systems
biology approach, which involves iterative rounds of experimental
manipulation and high-throughput profiling for refinement of
model predictions and a more insightful multi-dimensional view of
virus-host interactions [68]. Interpretation of this refined global
view of HCV-mediated cellular reprogramming will provide
valuable guidance in the design of novel antiviral therapeutics
aimed at modifying HCV infection and/or pathogenesis.
Supporting Information
Table S1 Comprehensive list of the 2,418 proteins quantified by
proteomic analysis of Huh-7.5 cells infected with HCV. Abun-
dance ratios were monitored 24, 48 and 72 h after infection with
either HCVcc (chimeric HCV 2a virus, J6/JFH-1) or UV-HCVcc
(UV-inactivated chimeric HCV 2a virus, J6/JFH-1) and using a
time-matched mock (conditioned media) as the reference. Final
protein abundance ratios and accompanying P-values were
calculated in Elucidator by combining data from the 5 strong
cation exchange (SCX) fractions generated and analyzed for each
sample. Also reported here are the log protein abundance ratio,
fold change, log error, and XDev (log ratio/log error). A total of
495 proteins were differentially regulated (.1.5-fold change,
P-Value,0.05) in at least two experiments and are highlighted in
bold. These proteins are arranged in order of the fold-change
observed in the HCVcc sample at 24 h post-infection.
Found at: doi:10.1371/journal.ppat.1000719.s001 (1.71 MB XLS)
Table S2 Select list of altered protein abundances reflecting
perturbations in host metabolism and adaptive responses during
HCV infection. Fold-change in protein abundance and accompany-
ing P-values were calculated in Elucidator as described in Table S1.
Differentially regulated proteins (.1.5-fold change, P-Value,0.05)
exhibiting statistically significant increases in abundance are
highlighted in red and those exhibiting statistically significant
decreases in abundance are highlighted in green. Functional
categories represented include glycolysis, the pentose phosphate
pathway, and the tricarboxylic acid (TCA) cycle whose constituents
are listed in their order of appearance in the appropriate pathway.
For all other functional categories typically representing a broader
spectrum of activities including pyruvate metabolism, oxidative
phosphorylation, glutamate metabolism, fatty acid oxidation, nucle-
otide biosynthesis and homeostasis, lipogenesis, chaperones, and
NRF2 stress response the proteins have been arranged in order of the
fold-change observed in the HCVcc sample at 24 h post-infection.
Found at: doi:10.1371/journal.ppat.1000719.s002 (0.07 MB XLS)
Table S3 Select list of 272 lipid species exhibiting significant
differences across conditions and time points (ANOVA P,0.05).
Mass to charge ratio (M/Z), normalized elution time (NET), log 2
average abundances (mean) and standard deviations (sd) are
presentedfor eachcondition (CM: conditioned media, UV-HCVcc:
UV-inactivated chimeric HCV 2a, HCVcc: chimeric HCV 2a
virus) and time point. Also reported are the overall P-values from
ANOVA analysis performed on minimum observation data (a
feature was required to be observed in at least two out of three
conditions (CM, UV-HCVcc, HCVcc) and there must be duplicate
measurements for the two out of three conditions). P-values listed as
0.000areequivalent top,0.001.NAindicateswheremissingvalues
exist. Among the 272 features exhibiting statistically significant
differences between treatment conditions and/or time points, 73
lipid species were identified by matching to a lipid AMT tag
database or fragmentation information collected via targeted MS/
MS analyses. Identity abbreviations were made for phoshatidylcho-
line (PC; O- fatty acid chain number means that an alkyl acyl
linkage to the glycerol chain is present for the respective PC),
sphingomyelin (SM), ceramide (Cer), triacylglycerol (TAG), and
cholesterol ester (CE). The notation further indicates total number
of carbons and double bonds however it does not discern
redundancy associated with varying fatty acid composition for the
same molecular weight.
Found at: doi:10.1371/journal.ppat.1000719.s003 (0.07 MB XLS)
Table S4 Top 5% of the bottlenecks identified from the combined
lipidomics, proteomics inferred and protein-protein interaction
network. Accompanying notes about the known or implicated roles
of the identified bottlenecks in HCV response is also included.
Found at: doi:10.1371/journal.ppat.1000719.s004 (0.03 MB XLS)
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